Somerset Trust CO Abb Vie Inc. Transaction History

Somerset Trust CO

$239 Million
Q1 2024

A detailed history of Somerset Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Somerset Trust CO holds 1,943 shares of ABBV stock, worth $318,341. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,943

Previous 1,790 8.55%

Holding current value

$318,341

Previous $277,000 27.44%

% of portfolio

0.15%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	BUY	$159.82 - $182.1 $24,452 - $27,861	153 Added 8.55%	1,943 $353,000
Q4 2023 Jan 08, 2024	SELL	$137.6 - $154.97 $48,022 - $54,084	-349 Reduced 16.32%	1,790 $277,000
Q3 2023 Oct 17, 2023	BUY	$133.59 - $154.65 $24,847 - $28,764	186 Added 9.52%	2,139 $318,000
Q2 2023 Jul 07, 2023	SELL	$132.51 - $164.9 $1,590 - $1,978	-12 Reduced 0.61%	1,953 $263,000
Q1 2023 Apr 05, 2023	SELL	$144.61 - $166.54 $41,358 - $47,630	-286 Reduced 12.71%	1,965 $313,000

Q4 2022 Jan 03, 2023	BUY	$138.31 - $165.87 $8,298 - $9,952	60 Added 2.74%	2,251 $364,000
Q3 2022 Oct 03, 2022	BUY	$134.21 - $153.93 $2,684 - $3,078	20 Added 0.92%	2,191 $294,000
Q2 2022 Jul 06, 2022	BUY	$137.62 - $174.96 $18,303 - $23,269	133 Added 6.53%	2,171 $333,000
Q1 2022 Apr 05, 2022	BUY	$131.98 - $163.75 $4,883 - $6,058	37 Added 1.85%	2,038 $330,000
Q4 2021 Jan 07, 2022	BUY	$107.43 - $135.93 $214,967 - $271,995	2,001 New	2,001 $271,000
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $19,644 - $25,110	-299 Closed	0 $0
Q1 2019 Apr 09, 2019	BUY	$77.14 - $90.79 $23,064 - $27,146	299 New	299 $24,000
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $38,409 - $42,698	-432 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $30,175 - $38,543	432	432 $38,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Trust CO with notifications on news.

Account

Somerset Trust CO Abb Vie Inc. Transaction History